Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
Goetz MP, Toft D, Reid J, Ames M, Stensgard B, Safgren S, Adjei AA, Sloan J, Atherton P, Vasile V, Salazaar S, Adjei A, Croghan G, Erlichman C.
Goetz MP, et al. Among authors: sloan j.
J Clin Oncol. 2005 Feb 20;23(6):1078-87. doi: 10.1200/JCO.2005.09.119.
J Clin Oncol. 2005.
PMID: 15718306
Clinical Trial.